BeeHero CEO Omer Davidi On Using Tech To Help Beekeepers Save Hives And Optimize Pollination
Assistant Managing Editor Diane Brady speaks with BeeHero CEO Omer Davidi at the 2023 APEC CEO Summit in San Francisco.#dianebrady #beehero #omerdavidi #apec (Source: Reuters: Health)
Source: Reuters: Health - November 26, 2023 Category: Consumer Health News Source Type: news
Added Leukotriene Receptor Antagonists Show Benefits in Chronic Urticaria
(MedPage Today) -- ANAHEIM, Calif. -- Adding leukotriene receptor antagonists (LTRAs) to antihistamines appears to reduce the severity of chronic urticaria, according to a systematic review and meta-analysis of randomized trials.
Among 33 unique... (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - November 15, 2023 Category: Neurology Source Type: news
Novel BTK Inhibitor for Chronic Hives Wins in Phase III Trials
(MedPage Today) -- ANAHEIM, Calif. -- Treatment with remibrutinib, an investigational Bruton's tyrosine kinase (BTK) inhibitor, led to fast improvement in symptom control for patients with chronic spontaneous urticaria (CSU) inadequately controlled... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - November 15, 2023 Category: Allergy & Immunology Source Type: news
Novel BTK Inhibitor for Chronic Hives Wins in Phase III Trial
(MedPage Today) -- ANAHEIM, Calif. -- Treatment with remibrutinib, an investigational Bruton's tyrosine kinase (BTK) inhibitor, led to fast improvement in symptom control for patients with chronic spontaneous urticaria (CSU) inadequately controlled... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - November 14, 2023 Category: Allergy & Immunology Source Type: news
Acupuncture Offers Some Benefit in Chronic Spontaneous Urticaria
TUESDAY, Nov. 14, 2023 -- For patients with chronic spontaneous urticaria (CSU), acupuncture produces a greater improvement in the Weekly Urticaria Activity Score (UAS7), although the difference is not clinically significant, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 14, 2023 Category: Pharmaceuticals Source Type: news
Acupuncture could help relieve chronic hives, Chinese study finds
Acupuncture may offer limited relief to patients with chronic hives, a new Chinese study indicates. (Source: Health News - UPI.com)
Source: Health News - UPI.com - November 13, 2023 Category: Consumer Health News Source Type: news
Treatment Plan for Chronic Spontaneous Urticaria
The hives of CSU can be tricky to manage. You and your doctor can try medications to ease your symptoms. But other changes might make a difference, too. (Source: WebMD Health)
Source: WebMD Health - November 8, 2023 Category: Consumer Health News Source Type: news
When the Hives of CSU Don ’t Go Away on Their Own
CSU can be frustrating, but the worst part might be when the hives don’t go away on their own. New treatments can help. (Source: WebMD Health)
Source: WebMD Health - November 8, 2023 Category: Consumer Health News Source Type: news
How Chronic Spontaneous Urticaria Is Different
Hives themselves are very common. So what sets chronic spontaneous urticaria apart? (Source: WebMD Health)
Source: WebMD Health - November 8, 2023 Category: Consumer Health News Source Type: news
Chronic Spontaneous Urticaria: What to Know
What you should know about chronic spontaneous urticaria (CSU), including symptoms, triggers, treatment, and a link to autoimmune disease. (Source: WebMD Health)
Source: WebMD Health - November 8, 2023 Category: Consumer Health News Source Type: news
Bruton ’s Tyrosine Kinase Signaling and Implications for CSU Bruton ’s Tyrosine Kinase Signaling and Implications for CSU
Join us to learn about the role of Bruton ’s tyrosine kinase (BTK) in chronic spontaneous urticaria (CSU) pathophysiology and the effect of BTK signal inhibition.Medscape Medical Affairs (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 1, 2023 Category: Consumer Health News Tags: None Virtual Symposium Source Type: news
Investigational BTK Inhibitor Shows Efficacy in Chronic Spontaneous Urticaria
(MedPage Today) -- Remibrutinib, an investigational Bruton's tyrosine kinase (BTK) inhibitor, was safe and efficacious in patients with chronic spontaneous urticaria (CSU), a phase IIb extension study showed.
In nearly 200 patients who received... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - October 24, 2023 Category: Allergy & Immunology Source Type: news
FDA Calls for More Data on Dupilumab for CSU Indication FDA Calls for More Data on Dupilumab for CSU Indication
In a letter, the FDA stated that additional efficacy data are required to support an approval for chronic spontaneous urticaria (CSU), according to the manufacturers of dupilumab.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - October 23, 2023 Category: Allergy & Immunology Tags: Dermatology News Source Type: news
FDA rejects Regeneron-Sanofi's Dupixent application for chronic hives, wants more data
(Source: Reuters: Health)
Source: Reuters: Health - October 20, 2023 Category: Consumer Health News Source Type: news
Beware risk of adverse events associated with GBCAs
Risks associated with gadolinium-based contrast agents (GBCAs) differ by drug, and clinicians would do well to educate themselves about these differences, according to research published October 14 in Expert Opinion on Drug Safety.To make the situation more complicated, not all possible adverse events from GBCAs are noted in drug packaging, wrote a team led by Lu Wang, PhD, of Yantai Yuhuangding Hospital in Yantai, China."Some adverse events [noted] in this study were not mentioned in the package inserts, which need more attention and research to ensure the clinical safety," the group explained.The U.S. Food and Drug Admin...
Source: AuntMinnie.com Headlines - October 17, 2023 Category: Radiology Authors: Kate Madden Yee Tags: Clinical News MRI Source Type: news
